Please login to the form below

Not currently logged in
Email:
Password:

Sativex cancer pain treatment goes on sale in Canada

GW Pharmaceuticals and co-marketing partner Bayer say that Health Canada has approved its cannabinoid-derived treatment Sativex as an adjunctive analgesic treatment in adults with advanced cancer pain

UK-headquartered GW Pharmaceuticals and co-marketing partner Bayer Inc, a subsidiary of German pharmaceutical firm Bayer, has revealed that Health Canada approved Sativex, a cannabis-derived pharmaceutical treatment, as adjunctive analgesic treatment in adult patients with advanced cancer pain.

Sativex is approved for treatment during the highest tolerated dose of strong opioid therapy for persistent background pain. It is also currently the only marketed pharmaceutical product derived from components of the cannabis plant and administered through a buccal spray.

Health Canada approved Sativex with conditions under the Notice of Compliance with Conditions policy (NOC/c). This authorisation reflects the promising nature of the clinical evidence which will be confirmed with further studies.

Health Canada approved Sativex for the treatment of neuropathic pain in adults with multiple sclerosis (MS) under the NOC/c policy in 2005.

Dr Geoffrey Guy, GW's chairman, said: "GW is delighted to receive Health Canada's regulatory approval for Sativex in the relief of cancer pain. Sativex has been shown to provide important pain relief to the most high need patients with advanced cancer. We are pleased to be able to offer the prospect of an improved quality of life for people who previously had little such opportunity."

Philip Blake, president and CEO of Bayer Inc, said: "Bayer HealthCare is committed to putting the needs of patients first and is very pleased that Sativex can now be used to manage cancer pain in Canada. Health Canada's approval of Sativex is further recognition of the important role this medicine can play in effective pain treatment."

7th August 2007

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Grace Communications

Grace Communications is an award winning, independent, full service, creative communications agency specialising in solving problems for healthcare brands....

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics